Clinical Trials Directory

Trials / Completed

CompletedNCT02655380

Remifentanil Requirement for Acceptable Intubating Condition

Remifentanil Requirement for Acceptable Intubating Condition With Two Dose Ketamine Without Neuromuscular Blocking Agent in Children

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
51 (actual)
Sponsor
Ajou University School of Medicine · Academic / Other
Sex
All
Age
3 Years – 12 Years
Healthy volunteers
Not accepted

Summary

Ketamine and opioid are known to improve the intubating condition, respectively. Combination of ketamine and opioid potentiate analgesic effect and give hemodynamic stability in complementary manner. Therefore, the combination use of ketamine and remifentanil could be useful for acceptable intubating condition in the general anesthesia without the use of neuromuscular blocking agent. Generally, induction dose of ketamine ranges between 1 and 2 mg. There was no report about the optimal dose of remifentanil with 1 or 2 mg ketamine induction dose for intubation without neuromuscular blocking agent. The investigators focus on remifentanil dose using Dixon's up and down method.

Conditions

Interventions

TypeNameDescription
DRUGKetamine 1Anesthesia induction is performed with 1 mg ketamine.
DRUGKetamine 2Anesthesia induction is performed with 2 mg ketamine.
DRUGRemifentanilAfter anesthesia induction with ketamine, predetermined remifentanil using Dixon's up and dowm method is administered.

Timeline

Start date
2017-06-19
Primary completion
2018-04-16
Completion
2018-04-16
First posted
2016-01-14
Last updated
2019-01-10

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02655380. Inclusion in this directory is not an endorsement.